Cargando…

Insights into the changes in the proteome of Alzheimer disease elucidated by a meta-analysis

Mass spectrometry (MS)-based proteomics is a powerful tool to explore pathogenic changes of a disease in an unbiased manner and has been used extensively in Alzheimer disease (AD) research. Here, by performing a meta-analysis of high-quality proteomic studies, we address which pathological changes a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haytural, Hazal, Benfeitas, Rui, Schedin-Weiss, Sophia, Bereczki, Erika, Rezeli, Melinda, Unwin, Richard D., Wang, Xusheng, Dammer, Eric B., Johnson, Erik C. B., Seyfried, Nicholas T., Winblad, Bengt, Tijms, Betty M., Visser, Pieter Jelle, Frykman, Susanne, Tjernberg, Lars O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642431/ https://www.ncbi.nlm.nih.gov/pubmed/34862388 http://dx.doi.org/10.1038/s41597-021-01090-8

Ejemplares similares

Monoamine oxidase B is associated with γ-secretase in cultured neurons and in brain
por: Weiss, Sophia Schedin, et al.
Publicado: (2013)

Distinctive alteration of presynaptic proteins in the outer molecular layer of the dentate gyrus in Alzheimer’s disease
por: Haytural, Hazal, et al.
Publicado: (2021)

Non-specific Detection of a Major Western Blotting Band in Human Brain Homogenates by a Multitude of Amyloid Precursor Protein Antibodies
por: Haytural, Hazal, et al.
Publicado: (2019)

Super-resolution microscopy reveals γ-secretase at both sides of the neuronal synapse
por: Schedin-Weiss, Sophia, et al.
Publicado: (2016)

Live Cell FRET Imaging Reveals Amyloid β-Peptide Oligomerization in Hippocampal Neurons
por: Gao, Yang, et al.
Publicado: (2021)

A Super-Resolved View of the Alzheimer’s Disease-Related Amyloidogenic Pathway in Hippocampal Neurons
por: Yu, Yang, et al.
Publicado: (2021)

Neuronal Aβ42 is enriched in small vesicles at the presynaptic side of synapses
por: Yu, Yang, et al.
Publicado: (2018)

The Proteome of the Dentate Terminal Zone of the Perforant Path Indicates Presynaptic Impairment in Alzheimer Disease
por: Haytural, Hazal, et al.
Publicado: (2020)

Changes in dementia diagnoses in Sweden during the COVID-19 pandemic
por: Axenhus, Michael, et al.
Publicado: (2022)

Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels
por: Schedin-Weiss, Sophia, et al.
Publicado: (2017)

Visualizing Active Enzyme Complexes Using a Photoreactive Inhibitor for Proximity Ligation – Application on γ-Secretase
por: Schedin-Weiss, Sophia, et al.
Publicado: (2013)

Microdissected Pyramidal Cell Proteomics of Alzheimer Brain Reveals Alterations in Creatine Kinase B-Type, 14-3-3-γ, and Heat Shock Cognate 71
por: Sandebring-Matton, Anna, et al.
Publicado: (2021)

γ-Secretase Dependent Production of Intracellular Domains Is Reduced in Adult Compared to Embryonic Rat Brain Membranes
por: Frånberg, Jenny, et al.
Publicado: (2010)

Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis
por: Jiang, Richeng, et al.
Publicado: (2022)

Changes in mortality trends amongst common diseases during the COVID-19 pandemic in Sweden
por: Axenhus, Michael, et al.
Publicado: (2021)

Glycan biomarkers for Alzheimer disease correlate with T‐tau and P‐tau in cerebrospinal fluid in subjective cognitive impairment
por: Schedin‐Weiss, Sophia, et al.
Publicado: (2020)

Proteomics Time-Course Study of App Knock-In Mice Reveals Novel Presymptomatic Aβ(42)-Induced Pathways to Alzheimer’s Disease Pathology
por: Schedin-Weiss, Sophia, et al.
Publicado: (2020)

Dual Bioorthogonal Labeling of the Amyloid-β Protein Precursor Facilitates Simultaneous Visualization of the Protein and Its Cleavage Products
por: van Husen, Lea S., et al.
Publicado: (2019)

What Can N-glycomics and N-glycoproteomics of Cerebrospinal Fluid Tell Us about Alzheimer Disease?
por: Gaunitz, Stefan, et al.
Publicado: (2021)

Neuronal Trafficking of the Amyloid Precursor Protein—What Do We Really Know?
por: Lin, Tong, et al.
Publicado: (2021)

The N‐glycan profile in cortex and hippocampus is altered in Alzheimer disease
por: Gaunitz, Stefan, et al.
Publicado: (2020)

Synaptic and Endosomal Localization of Active γ-Secretase in Rat Brain
por: Frykman, Susanne, et al.
Publicado: (2010)

Affinity pulldown of γ-secretase and associated proteins from human and rat brain
por: Teranishi, Yasuhiro, et al.
Publicado: (2010)

Proximity ligation assay reveals both pre- and postsynaptic localization of the APP-processing enzymes ADAM10 and BACE1 in rat and human adult brain
por: Lundgren, Jolanta L., et al.
Publicado: (2020)

A global review of penalties for abortion-related offences in 182 countries
por: Ambast, Sanhita, et al.
Publicado: (2023)

Lack of N-glycosylation increases amyloidogenic processing of the amyloid precursor protein
por: Lin, Tong, et al.
Publicado: (2022)

Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer’s disease biomarkers
por: Weiner, Sophia, et al.
Publicado: (2022)

Engineered Human Induced Pluripotent Cells Enable Genetic Code Expansion in Brain Organoids
por: van Husen, Lea S., et al.
Publicado: (2021)

The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease
por: Sandebring, Anna, et al.
Publicado: (2013)

Correction: The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease
por: Sandebring, Anna, et al.
Publicado: (2013)

Correction: The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease
por: Sandebring, Anna, et al.
Publicado: (2013)

Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population
por: Bertens, Daniela, et al.
Publicado: (2017)

Conformation‐specific antibodies against multiple amyloid protofibril species from a single amyloid immunogen
por: Bonito‐Oliva, Alessandra, et al.
Publicado: (2019)

Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer’s disease patients
por: Kirsebom, Bjørn Eivind, et al.
Publicado: (2022)

The effect of diagnostic criteria on outcome measures in preclinical and prodromal Alzheimer's disease: Implications for trial design
por: Bertens, Daniela, et al.
Publicado: (2017)

On the Physiology of Cells, with a View to Elucidate the Laws Regulating the Structure and Function of Glands
Publicado: (1849)

Advances in the measurement of coverage for RMNCH and nutrition: from contact to effective coverage
por: Amouzou, Agbessi, et al.
Publicado: (2019)

Gene therapy in Alzheimer’s disease – potential for disease modification
por: Nilsson, Per, et al.
Publicado: (2010)

Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal
por: Vermunt, Lisa, et al.
Publicado: (2019)

CSF proteomic signature predicts progression to Alzheimer's disease dementia
por: Vromen, Eleonora M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lndeunqa59m8llgk22v6p9ehru